ReviewInternational journal of molecular sciences2026
Diabetes Mellitus with Influenza Virus and Subsequent Bacterial Infection: Triple Pathological Interactions and Challenges.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Diabetes mellitus (DM), characterized by persistent hyperglycemia, not only induces chronic damage and dysfunction across multiple tissues and organs but also increases susceptibility to a broad spectrum of pathogens. Diabetes serves as a significant risk factor for influenza virus infection and associated secondary bacterial pneumonia. This review mainly focuses on the complex pathological and physiological interactions among type 2 diabetes mellitus, influenza and bacterial infections. Chronic hyperglycemia and the resulting immune-metabolic disorders lead to impaired innate and adaptive immune functions. Influenza virus infection further compromises the respiratory barrier, induces an excessive inflammatory response, and depletes immune cells, thereby creating an ideal microenvironment for bacterial colonization. The ensuing bacterial infection synergizes with the virus, forming a vicious cycle of pathogenesis. An integrated strategy combining optimized glycemic control, enhanced vaccination, and early, precise antiviral and antibacterial therapy is paramount for the prevention and treatment of secondary bacterial infections following influenza in patients with diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.